Bardy Diagnostics IPO

Bardy Diagnostics is the developer of a heart monitor known as Carnation Ambulatory Monitor (CAM™) that can be worn comfortably and discreetly for up to 14 days.

Register for Details

For more details on financing and valuation of private companies similar to Bardy Diagnostics before its M&A, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Bardy Diagnostics

To invest in Bardy Diagnostics pre-IPO

Can you invest in Bardy Diagnostics pre-IPO?

You can no longer invest in Bardy Diagnostics with Forge. But if you are an accredited investor interested in buying pre-IPO shares of a private company, you can learn more about how to invest in the private market or register today to get started.

Can you sell shares of Bardy Diagnostics before it goes public?

You can no longer sell shares of Bardy Diagnostics on Forge as this company is no longer private. However, if you own shares of a private company, Forge may be able to help you sell them in a way that works for you and the company. Learn more or register with us today to get started.

What is the pre-IPO value of my Bardy Diagnostics shares?

Forge can no longer determine the value of Bardy Diagnostics shares as this company is no longer private. However, if you own shares of a private company, Forge may help you value and sell them in a way that works for you and the company. Learn more or register with us today to get started.

Is Bardy Diagnostics a publicly traded company?

Bardy Diagnostics became a public company following its M&A on 08/16/2021 and is now a publicly traded company.

To learn more about Bardy Diagnostics potential IPO

Will Bardy Diagnostics go IPO?

Bardy Diagnostics became a public company following its M&A on 08/16/2021.

What is Bardy Diagnostics’ IPO price?

The IPO price of Bardy Diagnostics is not currently available.

When was Bardy Diagnostics founded?

Bardy Diagnostics was founded in 2013.

What is Bardy Diagnostics funding to date?

Bardy Diagnostics has raised $84.02MM to date.

Who are Bardy Diagnostics’s major investors?

Bardy Diagnostics Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
02/14/2020 Series B-1 $13MM $xx.xx $13.28B Health Enterprise Partners, River Cities Capital Funds, Sv Health Investors
Price per Share
$xx.xx
Shares Outstanding
10,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Health Enterprise Partners, River Cities Capital Funds, Sv Health Investors
04/16/2019 Series B $35.65MM $xx.xx $11.52B Aperture Venture Partners, Aphelion Capital, Ascension Ventures, Health Enterprise Partners, Healthquest Capital, Lumira Ventures, Rex Health Ventures, River Cities Capital Funds, Sv Health Investors
Price per Share
$xx.xx
Shares Outstanding
27,425,350
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Aperture Venture Partners, Aphelion Capital, Ascension Ventures, Health Enterprise Partners, Healthquest Capital, Lumira Ventures, Rex Health Ventures, River Cities Capital Funds, Sv Health Investors
07/16/2018 Series A $35.36MM $xx.xx $8.84B Ascension Ventures, Health Enterprise Partners, Sv Health Investors
Price per Share
$xx.xx
Shares Outstanding
30,254,053
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Ascension Ventures, Health Enterprise Partners, Sv Health Investors
Updated on: Nov 22, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.